Home
>
National Drug Code (NDC)
>
Isuprel
Isuprel - 0409-1410-05 - (ISOPROTERENOL HYDROCHLORIDE)
Drug Information of Isuprel
| Product NDC: | 0409-1410 |
| Proprietary Name: | Isuprel |
| Non Proprietary Name: | ISOPROTERENOL HYDROCHLORIDE |
| Active Ingredient(s): | .2 mg/mL & nbsp; ISOPROTERENOL HYDROCHLORIDE |
| Administration Route(s): | INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Isuprel
| Product NDC: | 0409-1410 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA010515 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120618 |
Package Information of Isuprel
| Package NDC: | 0409-1410-05 |
| Package Description: | 10 AMPULE in 1 CARTON (0409-1410-05) > 5 mL in 1 AMPULE |
NDC Information of Isuprel
| NDC Code | 0409-1410-05 |
| Proprietary Name | Isuprel |
| Package Description | 10 AMPULE in 1 CARTON (0409-1410-05) > 5 mL in 1 AMPULE |
| Product NDC | 0409-1410 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ISOPROTERENOL HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRACARDIAC; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20120618 |
| Marketing Category Name | NDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | ISOPROTERENOL HYDROCHLORIDE |
| Strength Number | .2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] |
